Foyston, Gordon, & Payne Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equifax
EFX
|
+$3.8M |
| 2 |
Ulta Beauty
ULTA
|
+$2.62M |
| 3 |
Valvoline
VVV
|
+$2.46M |
| 4 |
RELX
RELX
|
+$2.1M |
| 5 |
MRSH
Marsh
MRSH
|
+$1.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.35M |
| 2 |
Check Point Software Technologies
CHKP
|
+$2.23M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.17M |
| 4 |
SAP
SAP
|
+$2.13M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.3% |
| 2 | Technology | 20.94% |
| 3 | Industrials | 17.6% |
| 4 | Consumer Staples | 13.89% |
| 5 | Consumer Discretionary | 9.08% |
Similar funds
Foyston, Gordon, & Payne's Q4 2020 Portfolio in Review
As of Q4 2020, Foyston, Gordon, & Payne held 68 positions worth $414M, up 6.9% from $388M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $16.2M in Q4 2020, closing 3 positions and reducing 48 holdings. Its most notable exit was Check Point Software Technologies, an estimated $2.23M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.
Against the trend, Foyston, Gordon, & Payne opened a new position in Equifax worth $4.36M.
- Foyston, Gordon, & Payne's largest Q4 2020 buy was Equifax: 22,604 shares worth $4.36M.
- Foyston, Gordon, & Payne added most to Ulta Beauty in Q4 2020, an estimated $2.62M increase.
- Foyston, Gordon, & Payne's biggest Q4 2020 reduction was Microsoft, cutting an estimated $2.35M.
- Foyston, Gordon, & Payne fully exited Check Point Software Technologies in Q4 2020, selling an estimated $2.23M.
- Foyston, Gordon, & Payne's ten largest holdings make up 45% of its $414M portfolio in Q4 2020.
- Foyston, Gordon, & Payne opened 4 new positions and closed 3 in Q4 2020.
- Foyston, Gordon, & Payne's portfolio value rose 6.9% quarter-over-quarter to $414M.
Based on Foyston, Gordon, & Payne's 13F filing for Q4 2020, filed 12 Feb 2021.